Plunkett Research Online: Soleno Therapeutics

SOLENO THERAPEUTICS (SLNO) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome......


SOLENO THERAPEUTICS

Ticker: SLNO
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 213-8444
Fax: 650 213-8383
Address: 1235 Radio Road
Redwood City, CA 94065 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Anish BhatnagarCEO/COO/Director/President
James MackanessCFO/Chief Accounting Officer
See More
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome......See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture